4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine

4-{[3-氯-5-(三氟甲基)吡啶-2-基]氧基}-1'-{[1-(丙-2-基)-1H-咪唑-4-基]磺酰基}-1,4'-联哌啶

4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine (CAS 2097938-20-8) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C22H29ClF3N5O3S and a molecular weight of 536.0 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.
2097938-20-8
Jingsj CID
J-323443-9
Molecular Formula
C22H29ClF3N5O3S
Chinese Name
4-{[3-氯-5-(三氟甲基)吡啶-2-基]氧基}-1'-{[1-(丙-2-基)-1H-咪唑-4-基]磺酰基}-1,4'-联哌啶
Molecular Weight
536.0 g/mol
Category
Pharma Intermediates
Last updated
8/21/2026

No offers for this compound yet.

Request a quote

Frequently Asked Questions

What is the CAS number of 4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine?

The CAS number of 4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine is 2097938-20-8.

What are the molecular formula and molecular weight of 4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine?

4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine has molecular formula C22H29ClF3N5O3S and molecular weight 536.0 g/mol.

Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.

Last updated:

How to cite: Jingsj. "4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-1'-{[1-(propan-2-yl)-1H-imidazol-4-yl]sulfonyl}-1,4'-bipiperidine (CAS 2097938-20-8)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-323443-9 (accessed 2026-10-23).

Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.